Biovalley > Human HDL 2 Subfraction Protein
Human HDL 2 Subfraction Protein
Référence OPMA04367
Conditionnement : 1MG
Marque : Aviva Systems Biology
Human HDL 2 Subfraction Protein (OPMA04367)
| Datasheets/Manuals | Printable datasheet for OPMA04367 |
|---|
| Predicted Species Reactivity | Human |
|---|---|
| Product Format | Liquid Standard buffer, 100mM Sodium Chloride, 10mM Tris, 1mM EDTA (pH 7.4) with 1mM Sodium Azide |
| Application | Specific methodologies have not been tested using this product. |
| Additional Information | Inactivation: Not Applicable |
| Reconstitution and Storage | Store at 2-8°C. Do not freeze. |
| Purification | Purified |
| Concentration | 1.0 mg/ml (BioRad DC) |
| Purity | Sequential Density Ultracentrifugation at d 1.063-1.125 Devoid of VLDL, IDL, LDL, and HDL3 |
| Specificity | Lipoprotein, High Density (HDL) 2 Subfraction |
| Source | Human Normolipidemic Plasma |
| Warning | This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1-1.0%. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of distilled water. |
| Alias Symbols | apoAII, Apo-AII, ApoA-II |
|---|---|
| NCBI Gene Id | 336 |
| Protein Name | Apolipoprotein A-II |
| Uniprot ID | P02652 |
| Protein Accession # | NP_001634.1 |
Protein interactions
| Name | # of Products |
|---|---|
| APOA1BP | 38 |
| APOA2 | 19 |
| APOC1 | 39 |
| APOD | 17 |
| APOF | 38 |
| C4A | 40 |
| PLTP | 55 |
Biological pathways
| Name | # of Products |
|---|---|
| Cholesterol efflux | 92 |
| Cholesterol homeostasis | 162 |
| Diacylglycerol catabolic process | 9 |
| High-density lipoprotein particle assembly | 58 |
| High-density lipoprotein particle clearance | 64 |
| High-density lipoprotein particle remodeling | 84 |
| Interspecies interaction between organisms | 817 |
| Lipoprotein metabolic process | 108 |
| Low-density lipoprotein particle remodeling | 69 |
| Negative regulation of cholesterol import | 16 |
| Negative regulation of cholesterol transporter activity | 9 |
| Negative regulation of cytokine secretion involved in immune response | 90 |
| Negative regulation of lipase activity | 10 |
| Negative regulation of lipid catabolic process | 87 |
| Negative regulation of very-low-density lipoprotein particle remodeling | 45 |
| Phosphatidylcholine biosynthetic process | 45 |
| Phospholipid catabolic process | 33 |
| Phospholipid efflux | 83 |
| Positive regulation of cholesterol esterification | 75 |
| Positive regulation of interleukin-8 biosynthetic process | 38 |
| Positive regulation of lipid catabolic process | 29 |
| Protein folding | 257 |
| Regulation of protein stability | 34 |
| Response to glucose stimulus | 59 |
| Reverse cholesterol transport | 103 |
| Triglyceride metabolic process | 52 |
| Triglyceride-rich lipoprotein particle remodeling | 9 |
Biological process
| Name | # of Products |
|---|---|
| Acute inflammatory response | 17 |
| Cellular lipid metabolic process | 114 |
| Cholesterol efflux | 28 |
| Cholesterol homeostasis | 56 |
| Cholesterol metabolic process | 72 |
| Diacylglycerol catabolic process | 2 |
| High-density lipoprotein particle assembly | 8 |
| High-density lipoprotein particle clearance | 8 |
| High-density lipoprotein particle remodeling | 17 |
| Interspecies interaction between organisms | 281 |
| Lipid metabolic process | 172 |
| Lipoprotein metabolic process | 40 |
| Low-density lipoprotein particle remodeling | 11 |
| Negative regulation of cholesterol import | 2 |
| Negative regulation of cholesterol transport | 4 |
| Negative regulation of cholesterol transporter activity | 1 |
| Negative regulation of cytokine secretion involved in immune response | 13 |
| Negative regulation of lipase activity | 3 |
| Negative regulation of lipid catabolic process | 21 |
| Negative regulation of very-low-density lipoprotein particle remodeling | 5 |
| Organ regeneration | 59 |
| Phosphatidylcholine biosynthetic process | 13 |
| Phospholipid catabolic process | 10 |
| Phospholipid efflux | 14 |
| Positive regulation of cholesterol esterification | 9 |
| Positive regulation of interleukin-8 biosynthetic process | 11 |
| Positive regulation of lipid catabolic process | 9 |
| Protein folding | 164 |
| Regulation of intestinal cholesterol absorption | 9 |
| Regulation of protein stability | 19 |
| Response to drug | 323 |
| Response to estrogen stimulus | 71 |
| Response to glucocorticoid stimulus | 109 |
| Response to glucose stimulus | 72 |
| Reverse cholesterol transport | 22 |
| Small molecule metabolic process | 825 |
| Transport | 555 |
| Triglyceride metabolic process | 32 |
| Triglyceride-rich lipoprotein particle remodeling | 3 |
Cellular components
| Name | # of Products |
|---|---|
| Chylomicron | 13 |
| Endoplasmic reticulum lumen | 87 |
| Extracellular region | 1573 |
| Extracellular space | 884 |
| High-density lipoprotein particle | 22 |
| Spherical high-density lipoprotein particle | 9 |
| Very-low-density lipoprotein particle | 15 |
Protein function
| Name | # of Products |
|---|---|
| Apolipoprotein receptor binding | 46 |
| Cholesterol binding | 131 |
| Cholesterol transporter activity | 83 |
| High-density lipoprotein particle binding | 58 |
| High-density lipoprotein particle receptor binding | 46 |
| Lipase inhibitor activity | 24 |
| Lipid binding | 364 |
| Lipid transporter activity | 92 |
| Phosphatidylcholine binding | 23 |
| Phosphatidylcholine-sterol O-acyltransferase activator activity | 61 |
| Phospholipid binding | 197 |
| Protein binding | 12191 |
| Protein heterodimerization activity | 1132 |
| Protein homodimerization activity | 1852 |


